Assured Investment Management’s West Pharmaceutical WST Stock Holding History

Assured Investment Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-13,903	Closed	-$1.53M	–	866
2019 Q1	$1.53M	Buy	+13,903	New	+$1.45M	0.02%	307
2018 Q4	–	Sell	-13,185	Closed	-$1.63M	–	1339
2018 Q3	$1.63M	Buy	+13,185	New	+$1.48M	0.03%	462
2018 Q2	–	Sell	-12,108	Closed	-$1.07M	–	1345
2018 Q1	$1.07M	Sell	12,108 -524	-4%	-$49K	0.02%	523
2017 Q4	$1.25M	Sell	12,632 -9,168	-42%	-$899K	0.03%	420
2017 Q3	$2.1M	Sell	21,800 -6,556	-23%	-$593K	0.04%	322
2017 Q2	$2.68M	Sell	28,356 -15,281	-35%	-$1.41M	0.06%	215
2017 Q1	$3.56M	Buy	43,637 +39,466	+946%	+$3.3M	0.07%	114
2016 Q4	$354K	Sell	4,171 -55,537	-93%	-$4.37M	0.01%	474
2016 Q3	$4.45M	Buy	59,708 +40,444	+210%	+$3.21M	0.1%	108
2016 Q2	$1.46M	Buy	19,264 +17,528	+1,010%	+$1.28M	0.03%	198
2016 Q1	$120K	Buy	+1,736	New	+$104K	﹤0.01%	519

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Assured Investment Management's WST Position: Q2 2019 in Review

Assured Investment Management sold out of West Pharmaceutical (WST) in Q2 2019, closing a stake of 13,903 shares — an estimated $1.53M sold.

Assured Investment Management first reported a position in WST in Q1 2016 and held it in 11 quarters. The position peaked at $4.45M in Q3 2016. 374 funds tracked by Wall St. Rank hold WST as of Q2 2019.

Assured Investment Management reported no remaining West Pharmaceutical position as of Q2 2019 after selling out during the quarter.
Assured Investment Management sold 13,903 West Pharmaceutical shares in Q2 2019, an estimated $1.53M.
Assured Investment Management first reported a position in West Pharmaceutical in Q1 2016 and held it in 11 quarters.
Assured Investment Management's West Pharmaceutical position peaked at $4.45M in Q3 2016.
374 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.